Xiaofei Zhang

864 total citations
32 papers, 660 citations indexed

About

Xiaofei Zhang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaofei Zhang has authored 32 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Xiaofei Zhang's work include MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (4 papers) and Circular RNAs in diseases (4 papers). Xiaofei Zhang is often cited by papers focused on MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (4 papers) and Circular RNAs in diseases (4 papers). Xiaofei Zhang collaborates with scholars based in China, Japan and United States. Xiaofei Zhang's co-authors include Keke Li, Rong Zhang, Jiachang Cai, Hongwei Zhou, Gongxiang Chen, Wei‐Liang Chen, Yanyan Hu, Rongfu Tu, Weiguo Lü and Bingjian Lü and has published in prestigious journals such as Applied and Environmental Microbiology, Scientific Reports and Analytica Chimica Acta.

In The Last Decade

Xiaofei Zhang

29 papers receiving 656 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaofei Zhang 344 223 143 91 79 32 660
Jiajun Cui 475 1.4× 217 1.0× 143 1.0× 96 1.1× 111 1.4× 39 823
Xiaotian Dai 327 1.0× 117 0.5× 90 0.6× 96 1.1× 32 0.4× 29 594
Yonglie Zhou 198 0.6× 73 0.3× 92 0.6× 148 1.6× 104 1.3× 32 531
Shaoshan Han 424 1.2× 304 1.4× 85 0.6× 76 0.8× 44 0.6× 30 639
Xiaolong He 523 1.5× 234 1.0× 277 1.9× 33 0.4× 49 0.6× 33 785
K-John Cheung 435 1.3× 67 0.3× 148 1.0× 264 2.9× 46 0.6× 15 808
Weiqing Wu 284 0.8× 127 0.6× 70 0.5× 32 0.4× 35 0.4× 62 545
Xiaowen Chen 221 0.6× 87 0.4× 71 0.5× 35 0.4× 108 1.4× 26 419

Countries citing papers authored by Xiaofei Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Zhang more than expected).

Fields of papers citing papers by Xiaofei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Zhang. The network helps show where Xiaofei Zhang may publish in the future.

Co-authorship network of co-authors of Xiaofei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Zhang. A scholar is included among the top collaborators of Xiaofei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Zhang. Xiaofei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Ying, Jing Gao, Gang Zhang, et al.. (2025). Lignin: the primary component responsible for endocarp sclerosis in the development of Cornus officinalis fruit. BMC Plant Biology. 25(1). 1375–1375.
2.
Chen, Jingping, Lu Jin, Xiaofei Zhang, et al.. (2025). Predictive value of preoperative systemic immune-inflammation index and prognostic nutrition index in patients with epithelial ovarian cancer. Journal of Ovarian Research. 18(1). 45–45. 2 indexed citations
3.
Li, Xingxing, Zitong Wang, Ping Zhou, et al.. (2025). Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy. Journal of Translational Medicine. 23(1). 1233–1233.
4.
Guo, Dongyan, Jing Sun, Yajun Shi, et al.. (2024). Preparation of photo-controlled release ROS-responsive Ce6/elemene co-loaded liposomes and study on the effect on enhancing apoptosis of NMIBC. Biomedicine & Pharmacotherapy. 179. 117398–117398. 2 indexed citations
5.
Zhang, Xiaofei, et al.. (2023). Effects of a false-positive result in newborn congenital hypothyroidism screening on parents in Guangxi, China. Frontiers in Pediatrics. 11. 1134923–1134923. 2 indexed citations
6.
Zhang, Xiaofei, Qi Yang, Jingjing Huang, et al.. (2023). Clinical and molecular analysis of Guangxi patients with Kabuki syndrome and KMT2D mutations. Heliyon. 9(10). e20223–e20223. 1 indexed citations
7.
8.
Li, Mengting, Qi Yang, Xiaofei Zhang, et al.. (2022). Novel SLC12A1 mutations cause Bartter syndrome in two patients with different prognoses. Clinica Chimica Acta. 531. 120–125. 3 indexed citations
9.
Zhang, Wenbiao, Yongjiang Li, Guanjun Chen, et al.. (2022). Integrin α6-Targeted Molecular Imaging of Central Nervous System Leukemia in Mice. Frontiers in Bioengineering and Biotechnology. 10. 812277–812277. 5 indexed citations
10.
11.
Wang, Wenyu, et al.. (2021). Downregulation of miR‐3934 in Peripheral Blood Mononuclear Cells of Asthmatic Patients and Its Potential Diagnostic Value. BioMed Research International. 2021(1). 8888280–8888280. 1 indexed citations
12.
Zhang, Xiaofei, et al.. (2021). Advances in CpG Island Methylator Phenotype Colorectal Cancer Therapies. Frontiers in Oncology. 11. 629390–629390. 19 indexed citations
13.
Li, Mingjun, et al.. (2020). Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6. Cancer Cell International. 20(1). 574–574. 25 indexed citations
14.
Liang, Yun, Weiguo Lü, Xiaofei Zhang, & Bingjian Lü. (2018). Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer. Diagnostic Pathology. 13(1). 93–93. 43 indexed citations
15.
Zhang, Xiaofei, et al.. (2018). Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer. OncoTargets and Therapy. Volume 11. 3979–3987. 118 indexed citations
16.
Zhang, Xiaofei, Rongqin Sun, Yifan Jia, et al.. (2016). Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents. Scientific Reports. 6(1). 33204–33204. 60 indexed citations
17.
Zhang, Xiaofei, Hideki Shimodaira, Keigo Komine, et al.. (2016). CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer. International Journal of Clinical Oncology. 21(6). 1091–1101. 21 indexed citations
18.
Duan, Yunfei, Feng Zhu, Xiaodong Li, et al.. (2015). Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis. Tumor Biology. 36(7). 5081–5087. 11 indexed citations
19.
Qiu, Chunfang, Chuanxi Chen, Weixing Zhang, et al.. (2015). Fat‐Modified Enteral Formula Improves Feeding Tolerance in Critically Ill Patients: A Multicenter, Single‐Blind, Randomized Controlled Trial. Journal of Parenteral and Enteral Nutrition. 41(5). 785–795. 34 indexed citations
20.
Ji, Mei, Yan Liu, Qing Li, et al.. (2015). PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation. Journal of Translational Medicine. 13(1). 5–5. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026